Market Value9,482,104,000
Total Holdings134
File Date2016-05-16
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NLTX / Neoleukin Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
WINT / Windtree Therapeutics, Inc.
VTAE / Vitae Pharmaceuticals, Inc.
ONCE / Spark Therapeutics, Inc.
ABUS / Arbutus Biopharma Corporation
CNCE / Concert Pharmaceuticals Inc
AAAP / Advanced Accelerator Applications S.A
GNMX / Aevi Genomic Medicine, Inc.
30161QAC8 / Exelixis, Inc. Bond
IRWD / Ironwood Pharmaceuticals, Inc.
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
ABBV / AbbVie Inc.
PTN / Palatin Technologies, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
JUNO / Juno Therapeutics, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
OSIR / Osiris Therapeutics, Inc.
XNCR / Xencor, Inc.
ECYT / Endocyte, Inc.
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
98411CAB6 / XenoPort, Inc. Bonds 2.5% 2/1/2022
375558AP8 / Gilead Sciences, Inc. Bond 1.625% 5/1/16
220480AB3 / Amrn 3.5 1/32 Bond
PRQR / ProQR Therapeutics N.V.
DMTX / Dimension Therapeutics, Inc.
Arrowhead Research Corp. / (042797209)
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
451731103 / Ignyta, Inc.
APTO / Aptose Biosciences Inc.
MDWD / MediWound Ltd.
IMDZ / Immune Design Corp.
032420AC5 / Anacor Pharmaceuticals Inc. Bond 2.0% 15 OCT 2021
LGND / Ligand Pharmaceuticals Incorporated
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
US33830X1046 / Five Prime Therapeutics Inc
SVRA / Savara Inc.
EXEL / Exelixis, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
ARCT / Arcturus Therapeutics Holdings Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
NDRM / NeuroDerm Ltd.
XNPT / XenoPort, Inc.
FMI / Foundation Medicine, Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
AERI / Aerie Pharmaceuticals Inc
MDVN / Medivation, Inc.
CYTR / LadRx Corp
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
032420101 / Anacor Pharmaceuticals, Inc.
GWP / GW Pharmaceuticals plc
NVIV / InVivo Therapeutics Holdings Corp.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
FLXN / Horizon Funds - Horizon Flexible Income ETF
NBRV / Nabriva Therapeutics Plc
GHDX / Genomic Health, Inc.
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
ZGNX / Zogenix Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
QURE / uniQure N.V.
EPZM / Epizyme Inc
NBSE / NeuBase Therapeutics, Inc.
INSM / Insmed Incorporated
ACOR / Acorda Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
IDRA / Idera Pharmaceuticals, Inc.
TRIL / Trillium Therapeutics Inc
QLGN / Qualigen Therapeutics, Inc.
SGMO / Sangamo Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
STML / Stemline Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
DYAX / Dyax Corp.
DERM / Journey Medical Corporation
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
BDSI / Biodelivery Sciences International
TRVN / Trevena, Inc.
MCRB / Seres Therapeutics, Inc.
/ Achaogen Inc
MGNX / MacroGenics, Inc.
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
ITCI / Intra-Cellular Therapies, Inc.
GILD / Gilead Sciences, Inc.
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ALKS / Alkermes plc
CERS / Cerus Corporation
KPTI / Karyopharm Therapeutics Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
XLRN / Acceleron Pharma Inc
CMRX / Chimerix, Inc.
TARA / Protara Therapeutics, Inc.
INCY / Incyte Corporation
ARAV / Aravive, Inc.
LOXO / Loxo Oncology, Inc.
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
AUPH / Aurinia Pharmaceuticals Inc.
/ Array BioPharma, Inc.
ISEE / IVERIC bio Inc
VIRX / Viracta Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
MRNS / Marinus Pharmaceuticals, Inc.
ALDX / Aldeyra Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
ADMS / Adamas Pharmaceuticals Inc
IOVA / Iovance Biotherapeutics, Inc.
OMER / Omeros Corporation
CPRX / Catalyst Pharmaceuticals, Inc.
SRRA / Sierra Oncology Inc
DSCI / Derma Sciences, Inc.
BLCM / Bellicum Pharmaceuticals, Inc.
CRIS / Curis, Inc.
CCXI / ChemoCentryx Inc
TENX / Tenax Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
NVAX / Novavax, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
HRTX / Heron Therapeutics, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
LIFE / aTyr Pharma, Inc.
DVAX / Dynavax Technologies Corporation
BMRN / BioMarin Pharmaceutical Inc.
IMGN / ImmunoGen, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
AFMD / Affimed N.V.
BLUE / bluebird bio, Inc.
NTRA / Natera, Inc.
ASMB / Assembly Biosciences, Inc.
NVTA / Invitae Corporation
MRTX / Mirati Therapeutics, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)